NGS advances: Efficient fusion event detection in haematological malignancy clinical research

This study highlights the ability of the SureSeq™ Myeloid Fusion Panel to detect multiple fusions, identify breakpoints, and capture MECOM overexpression, so your lab can achieve higher efficiency sample classification with a single assay.

This application note will evidence:

• The concordance of the SureSeq Myeloid Fusion Panel with orthogonal methods
• The panel's confident detection of MECOM expression
• The partner-agnostic fusion detection capability of the panel, including breakpoints identified in 3 KMT2A rearrangements